China, Aug. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Combined anti-inflammatory drugs for the prevention of postoperative delirium in patients undergoing coronary artery bypass grafting and the construction of a multimodal intelligent prediction model: a multicenter, prospective, open, randomized controlled study'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130129
Registration Time: 2026/08/14
Type: Interventional study
Primary Sponsor: Beijing Jishuitan Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=334415
Published by HT Digital Content Services with permission from Health Daily Digest....